NCT00693069View on ClinicalTrials.gov

Effect of Different Dosing Regimens of Clopidogrel Before Elective Percutaneous Coronary Intervention (PCI) on Platelet Function

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

April 30, 2006

Conditions
Coronary Artery Disease
Interventions
DRUG

Clopidogrel

clopidogrel 300 mg on the day prior to angiography

DRUG

Clopidogrel

clopidogrel 600 mg on the day prior to angiography

DRUG

Clopidogrel

clopidogrel 300 mg followed by 75 mg daily started one week prior to angiography

DRUG

Clopidogrel

clopidogrel 300 mg followed by 150 mg daily started one week prior to angiography

Trial Locations (1)

H4J 1C5

Hopital du Sacre-Coeur de Montreal, Montreal

All Listed Sponsors
lead

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

OTHER

NCT00693069 - Effect of Different Dosing Regimens of Clopidogrel Before Elective Percutaneous Coronary Intervention (PCI) on Platelet Function | Biotech Hunter | Biotech Hunter